Leading brokers name 3 ASX shares to buy today

ASX shares Business man marking buy on board and underlining it

ASX shares Business man marking buy on board and underlining itWith so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares leading brokers have named as buys this week are listed below. Here’s why they are bullish on them:

Appen Ltd (ASX: APX)

According to a note out of Citi, its analysts have retained their buy rating and $9.15 price target on this artificial intelligence data services company’s shares. This follows an update out of Meta (Facebook), which revealed an increase in artificial intelligence and machine learning investment. Citi feels this bodes well for Appen given how Facebook is one of the company’s biggest customers. The Appen share price is trading at $6.39 on Monday afternoon.

Coles Group Ltd (ASX: COL)

A note out of Morgans reveals that its analysts have retained their add rating and lifted their price target on this supermarket giant’s shares to $20.65. Morgans highlights that Coles delivered a third quarter sales update slightly ahead of its estimates. It feels this was a big positive given the major disruptions during the period. Overall, the broker continues to see Coles as a good value option with defensive qualities and the capacity to invest in growth opportunities. The Coles share price is fetching $18.52 today.

ResMed Inc (ASX: RMD)

Analysts at Goldman Sachs have retained their buy rating but trimmed their price target on this sleep treatment company’s shares to $33.70. Goldman notes that ResMed’s quarterly update highlighted that supply chain pressures remain acute and the near-term upside from the key competitor recall remains more limited than hoped. Nevertheless, the broker believes ResMed is still in a stronger position today than 12 months ago and does not believe the near term challenges should be overcapitalised. The ResMed share price is trading at $28.63 on Monday.

The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Appen Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended COLESGROUP DEF SET. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/rKcNuBS

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s